Developer docs
API playgroundTry for free, no card

Search company profiles

Eden Brew

Full company profile

uuid00022al

Namestring
Eden Brew
Legal namestring
Eden Brew
Websiteurl
edenbrew.com.au
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Eden Brew is an Australian precision fermentation food technology company that produces animal-free dairy proteins using engineered yeast. Founded in 2021 in Melbourne as a spin-out of CSIRO research, with Norco Dairy Co-operative and Main Sequence Ventures as co-founding partners, the company has evolved from a consumer-focused animal-free milk effort into a B2B ingredient platform company. Its core technology replicates the natural casein micelle structure of milk — the protein complex responsible for slow-release mineral delivery — without using cows, producing a recombinant beta-casein protein (BCPP1) via microbial fermentation.

The company's commercial platform, DeepForte™, is positioned as a programmable casein micelle delivery system engineered to carry minerals such as iron, magnesium, and zinc through digestion and release them at the point of absorption. The platform offers four functional benefits: slow-release delivery for improved bioavailability, encapsulation for flavor masking and oxidation protection, high nutrient payload density, and clean-label formulation without synthetic chelators or harsh chemical carriers. Target applications span high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health and anaemia products, sports and performance nutrition, and engineered dairy ingredients for the broader food industry.

Eden Brew operates as a B2B ingredient supplier with a quote-based, contract-driven pricing model targeting food and supplement manufacturers in Australia and New Zealand. Revenue generation is gated by a regulatory submission to Food Standards Australia New Zealand (FSANZ) — the first such filing for a precision-fermented milk protein, with a decision expected by mid-November 2026. The company has raised approximately $23.3 million across seed and Series A funding rounds and employs 11-50 staff across protein science, fermentation, bioprocess, analytics, R&D, finance, and strategy functions.

Short descriptiontext

Eden Brew is a Melbourne-based precision fermentation company producing animal-free recombinant beta-casein protein via engineered yeast. It supplies the DeepForte™ B2B casein micelle platform to food and supplement manufacturers in Australia and New Zealand for slow-release nutrient delivery.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision fermentation ingredients, animal-free dairy proteins, casein micelle platform, B2B food ingredients, mineral delivery supplements
Industry2 codes
PRIMARYAFAFAGAG
Sports/Energy/Functional Concentrate Premixes (electrolyte, caffeine, vitamin bases)
Agriculture & Food Production/Beverage Production/Concentrates, Syrups & Flavor Bases Manufacturing
SECONDARYAFAFABAH
Functional/Fortified Beverage Production (Vitamins, Botanicals, Nootropics)
Agriculture & Food Production/Beverage Production/Non-Alcoholic Beverage Production (Soft Drinks, Juice, RTD)
NAICS code1 code
  • Flavoring Syrup and Concentrate Manufacturing311930
SIC code1 code
  • Food And Kindred Products2000
Product category
Precision Fermentation Dairy Protein Ingredients
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1B2B Ingredient Sales
TypeOne Time License
Description

Selling DeepForte™ casein protein ingredients to food and supplement manufacturers. Target applications include high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health and anaemia products, and sports nutrition. Revenue model focuses on ingredient supply to manufacturers rather than direct consumer products.

edenbrew.com.au
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Pricing details1 tier
1Quote-based B2B ingredient pricing for DeepForte™ platform
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing for B2B ingredients not publicly disclosed. The company operates as a B2B supplier to food and supplement manufacturers, with pricing likely negotiated on a contract basis.

edenbrew.com.au
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1DeepForte
Description

A programmable casein micelle platform designed for slow-release nutrient delivery, enabling encapsulation, nutrient density, and clean label formulations for supplements, fortified foods, and GLP-1 companion nutrition.

edenbrew.com.au
Core offering1 text field

Eden Brew develops and supplies DeepForte™, a programmable casein micelle nutrition delivery platform, and BCPP1, a recombinant beta-casein protein produced via precision fermentation using engineered yeast. The company sells these B2B ingredient solutions to food and supplement manufacturers for applications including high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health products, and sports nutrition.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 70% fewer emissions compared to conventional dairy
+3 more records
Product overview1 text field

Eden Brew operates as a B2B precision fermentation company offering two core offerings: the DeepForte™ platform—a programmable casein micelle technology for slow-release nutrient delivery—and BCPP1, a recombinant beta-casein protein ingredient produced via microbial fermentation using engineered yeast. DeepForte™ functions as the delivery technology that enables BCPP1 to carry minerals like iron, magnesium, and zinc, while BCPP1 serves as the foundational animal-free protein ingredient. The platform targets high-value markets including supplements, sports nutrition, GLP-1 companion nutrition, women's health, and fortified foods and beverages.

Product and service2 records
1DeepForte™
CategoryPrecision Fermentation Ingredient Platform
Description

A programmable casein micelle nutrition delivery platform that replicates natural milk digestion processes. Enables slow-release nutrient delivery with improved bioavailability for iron, magnesium, zinc, and other minerals; supports encapsulation for flavor masking and oxidation protection; and offers clean-label positioning without synthetic chelators. Sold as a B2B ingredient platform to food and supplement manufacturers.

2BCPP1 (Beta-Casein Protein Preparation)
CategoryAnimal-Free Dairy Protein Ingredient
Description

Recombinant beta-casein protein produced via microbial fermentation using engineered yeast. Designed as an animal-free dairy protein ingredient for use in supplements, food fortification, sports nutrition, and GLP-1 companion nutrition applications.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based precision fermentation dairy protein pioneer producing animal-free whey and casein via engineered microbes. Direct competitor to Eden Brew in B2B casein ingredient supply, with significantly more capital raised, existing FDA self-GRAS status, and partnerships with Nestlé and Mars.

TypeDirect peer
Description

Israel-based precision fermentation company producing animal-free milk proteins (including casein) for B2B food and beverage applications. Operates in the same core category as Eden Brew with a similar precision fermentation thesis targeting food manufacturers.

TypeDirect peer
Description

Israel-based precision fermentation startup producing animal-free dairy proteins (casein and whey) specifically for B2B food and beverage ingredient applications. Closely aligned with Eden Brew's pivot to a B2B ingredient platform.

TypeDirect peer
Description

New Zealand-based precision fermentation startup producing animal-free dairy proteins via engineered yeast. Direct geographic and technology peer to Eden Brew, both leveraging Southern Hemisphere dairy science ecosystems (CSIRO counterpart, AgResearch).

5Bon Vivant
TypeDirect peer
Description

France-based precision fermentation company developing animal-free casein and whey proteins for B2B food industry applications. Comparable technology stack and B2B go-to-market to Eden Brew's DeepForte™.

TypeDirect peer
Description

Netherlands-based precision fermentation B2B ingredient company producing animal-free dairy proteins, founded by dairy industry incumbents (FrieslandCampina, DSM-firmenich). Direct competitor to Eden Brew in the B2B casein ingredient space, with stronger industrial backing.

TypeEmerging player
Description

Canada-based precision fermentation startup producing animal-free dairy proteins via engineered yeast. Emerging direct competitor with a similar technology and B2B ingredients focus, though at an earlier stage than Eden Brew.

TypeEmerging player
Description

US precision fermentation company producing functional proteins (initially human lactoferrin) for nutrition applications using engineered yeast. Comparable technology platform and B2B ingredient model, focused on bioactives rather than bulk casein.

9Zero Cow Factory
TypeEmerging player
Description

India-based precision fermentation startup producing animal-free milk proteins including casein. Uses a similar precision fermentation approach and targets B2B dairy ingredient applications in Asia.

TypeEmerging player
Description

Singapore/US precision fermentation company producing functional dairy proteins (including lactoferrin and casein ingredients) for nutrition applications. Comparable precision fermentation B2B ingredients model with a focus on premium nutrition verticals.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Eden Brew

Precision Fermentation Dairy Protein Ingredientsedenbrew.com.au

Eden Brew is a Melbourne-based precision fermentation company producing animal-free recombinant beta-casein protein via engineered yeast. It supplies the DeepForte™ B2B casein micelle platform to food and supplement manufacturers in Australia and New Zealand for slow-release nutrient delivery.

What Eden Brew does

Eden Brew is an Australian precision fermentation food technology company that produces animal-free dairy proteins using engineered yeast. Founded in 2021 in Melbourne as a spin-out of CSIRO research, with Norco Dairy Co-operative and Main Sequence Ventures as co-founding partners, the company has evolved from a consumer-focused animal-free milk effort into a B2B ingredient platform company. Its core technology replicates the natural casein micelle structure of milk — the protein complex responsible for slow-release mineral delivery — without using cows, producing a recombinant beta-casein protein (BCPP1) via microbial fermentation.

The company's commercial platform, DeepForte™, is positioned as a programmable casein micelle delivery system engineered to carry minerals such as iron, magnesium, and zinc through digestion and release them at the point of absorption. The platform offers four functional benefits: slow-release delivery for improved bioavailability, encapsulation for flavor masking and oxidation protection, high nutrient payload density, and clean-label formulation without synthetic chelators or harsh chemical carriers. Target applications span high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health and anaemia products, sports and performance nutrition, and engineered dairy ingredients for the broader food industry.

Eden Brew operates as a B2B ingredient supplier with a quote-based, contract-driven pricing model targeting food and supplement manufacturers in Australia and New Zealand. Revenue generation is gated by a regulatory submission to Food Standards Australia New Zealand (FSANZ) — the first such filing for a precision-fermented milk protein, with a decision expected by mid-November 2026. The company has raised approximately $23.3 million across seed and Series A funding rounds and employs 11-50 staff across protein science, fermentation, bioprocess, analytics, R&D, finance, and strategy functions.

Eden Brew firmographics

Firmographics
Name
Eden Brew
Legal name
Eden Brew
Website
https://edenbrew.com.au
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Eden Brew is a Melbourne-based precision fermentation company producing animal-free recombinant beta-casein protein via engineered yeast. It supplies the DeepForte™ B2B casein micelle platform to food and supplement manufacturers in Australia and New Zealand for slow-release nutrient delivery.
Ownership category
akta.pro rank

Eden Brew industry classification

Industry
Product category
Precision Fermentation Dairy Protein Ingredients
NAICS
Flavoring Syrup and Concentrate Manufacturing (311930)
SIC
Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFAFAGAG
Sports/Energy/Functional Concentrate Premixes (electrolyte, caffeine, vitamin bases)
Agriculture & Food Production/Beverage Production/Concentrates, Syrups & Flavor Bases Manufacturing
SECONDARYAFAFABAH
Functional/Fortified Beverage Production (Vitamins, Botanicals, Nootropics)
Agriculture & Food Production/Beverage Production/Non-Alcoholic Beverage Production (Soft Drinks, Juice, RTD)

Keywords

  • Precision fermentation ingredients
  • Animal-free dairy proteins
  • Casein micelle platform
  • B2B food ingredients
  • Mineral delivery supplements

Where Eden Brew is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Eden Brew business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. B2B Ingredient Sales: Selling DeepForte™ casein protein ingredients to food and supplement manufacturers. Target applications include high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health and anaemia products, and sports nutrition. Revenue model focuses on ingredient supply to manufacturers rather than direct consumer products.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based B2B ingredient pricing for DeepForte™ platform

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Eden Brew product offering

Product offering

Core offering

Eden Brew develops and supplies DeepForte™, a programmable casein micelle nutrition delivery platform, and BCPP1, a recombinant beta-casein protein produced via precision fermentation using engineered yeast. The company sells these B2B ingredient solutions to food and supplement manufacturers for applications including high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health products, and sports nutrition.

Product overview

Eden Brew operates as a B2B precision fermentation company offering two core offerings: the DeepForte™ platform—a programmable casein micelle technology for slow-release nutrient delivery—and BCPP1, a recombinant beta-casein protein ingredient produced via microbial fermentation using engineered yeast. DeepForte™ functions as the delivery technology that enables BCPP1 to carry minerals like iron, magnesium, and zinc, while BCPP1 serves as the foundational animal-free protein ingredient. The platform targets high-value markets including supplements, sports nutrition, GLP-1 companion nutrition, women's health, and fortified foods and beverages.

Differentiator

Problem solved

Functional benefit

Brands

  • DeepForte: A programmable casein micelle platform designed for slow-release nutrient delivery, enabling encapsulation, nutrient density, and clean label formulations for supplements, fortified foods, and GLP-1 companion nutrition.

Products and services

  • DeepForte™ A programmable casein micelle nutrition delivery platform that replicates natural milk digestion processes. Enables slow-release nutrient delivery with improved bioavailability for iron, magnesium, zinc, and other minerals; supports encapsulation for flavor masking and oxidation protection; and offers clean-label positioning without synthetic chelators. Sold as a B2B ingredient platform to food and supplement manufacturers.
  • BCPP1 (Beta-Casein Protein Preparation) Recombinant beta-casein protein produced via microbial fermentation using engineered yeast. Designed as an animal-free dairy protein ingredient for use in supplements, food fortification, sports nutrition, and GLP-1 companion nutrition applications.

Quantifiable outcome

  • 70% fewer emissions compared to conventional dairy
  • +3 more outcomes

Companies that use Eden Brew

Customer profile

Segments6 records

Ideal customer profiles1 record

Eden Brew technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Eden Brew partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Eden Brew competitors and assessment

Company assessment

Direct peers

  • Perfect Day: US-based precision fermentation dairy protein pioneer producing animal-free whey and casein via engineered microbes. Direct competitor to Eden Brew in B2B casein ingredient supply, with significantly more capital raised, existing FDA self-GRAS status, and partnerships with Nestlé and Mars.
  • Remilk: Israel-based precision fermentation company producing animal-free milk proteins (including casein) for B2B food and beverage applications. Operates in the same core category as Eden Brew with a similar precision fermentation thesis targeting food manufacturers.
  • Imagindairy: Israel-based precision fermentation startup producing animal-free dairy proteins (casein and whey) specifically for B2B food and beverage ingredient applications. Closely aligned with Eden Brew's pivot to a B2B ingredient platform.
  • Daisy Lab: New Zealand-based precision fermentation startup producing animal-free dairy proteins via engineered yeast. Direct geographic and technology peer to Eden Brew, both leveraging Southern Hemisphere dairy science ecosystems (CSIRO counterpart, AgResearch).
  • Bon Vivant: France-based precision fermentation company developing animal-free casein and whey proteins for B2B food industry applications. Comparable technology stack and B2B go-to-market to Eden Brew's DeepForte™.
  • Vivici: Netherlands-based precision fermentation B2B ingredient company producing animal-free dairy proteins, founded by dairy industry incumbents (FrieslandCampina, DSM-firmenich). Direct competitor to Eden Brew in the B2B casein ingredient space, with stronger industrial backing.

Emerging players

  • Opalia: Canada-based precision fermentation startup producing animal-free dairy proteins via engineered yeast. Emerging direct competitor with a similar technology and B2B ingredients focus, though at an earlier stage than Eden Brew.
  • Helaina: US precision fermentation company producing functional proteins (initially human lactoferrin) for nutrition applications using engineered yeast. Comparable technology platform and B2B ingredient model, focused on bioactives rather than bulk casein.
  • Zero Cow Factory: India-based precision fermentation startup producing animal-free milk proteins including casein. Uses a similar precision fermentation approach and targets B2B dairy ingredient applications in Asia.
  • TurtleTree: Singapore/US precision fermentation company producing functional dairy proteins (including lactoferrin and casein ingredients) for nutrition applications. Comparable precision fermentation B2B ingredients model with a focus on premium nutrition verticals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Eden Brew social profiles

Digital presence

Eden Brew financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Eden Brew leadership team

Management profile

Number of profiles

Profiles11 records

Eden Brew funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Eden Brew M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eden Brew

What does Eden Brew do?

Eden Brew develops and supplies DeepForte™, a programmable casein micelle nutrition delivery platform, and BCPP1, a recombinant beta-casein protein produced via precision fermentation using engineered yeast. The company sells these B2B ingredient solutions to food and supplement manufacturers for applications including high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health products, and sports nutrition.

Is Eden Brew a public or private company?

Eden Brew is a private company. It is classified as venture growth investor backed and is currently operating.

When was Eden Brew founded?

Eden Brew was founded in 2021. It employs 11 to 50 people.

Where is Eden Brew based?

Eden Brew is headquartered in Melbourne, Australia, in the Oceania region.

How does Eden Brew make money?

One revenue line is on record: B2B Ingredient Sales.

Who are Eden Brew's main competitors?

Direct peers on record are Perfect Day, Remilk, Imagindairy, Daisy Lab, Bon Vivant and Vivici. Emerging players are Opalia, Helaina, Zero Cow Factory and TurtleTree.

Does Eden Brew have an API?

No public API is recorded for Eden Brew.

What industry is Eden Brew in?

Eden Brew's product category is Precision Fermentation Dairy Protein Ingredients. Its primary akta.pro industry code is AFAFAGAG, Sports/Energy/Functional Concentrate Premixes (electrolyte, caffeine, vitamin bases), with a secondary code of AFAFABAH, Functional/Fortified Beverage Production (Vitamins, Botanicals, Nootropics). Its NAICS code is 311930 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GreenqueenExclusive: Eden Brew Earns US GRAS Status for Cow-Free Casein, Eyes Supplements SpaceAustralian precision fermentation startup Eden Brew has received GRAS (Generally Recognized as Safe) status from the US Food and Drug Administration for its cow-free recombinant beta-casein protein, enabling it to enter the US market. The company, which filed for regulatory approval in Australia and New Zealand through FSANZ in November, has pivoted its commercialization strategy from selling dairy products under its own brand to targeting the health and supplements industry first, citing investor and market shifts. Eden Brew is now planning a $20M Series B funding round to scale up production, having already secured approximately $15M in funding, and aims to achieve price parity with conventional dairy by 2029.GreenqueenEden Brew Eyes 2026 Approval of Animal-Free Milk Protein in Australia & New ZealandAustralian food tech startup Eden Brew has submitted the first regulatory application in Australia and New Zealand for a precision-fermented animal-free dairy protein, with Food Standards Australia New Zealand (FSANZ) officially accepting the filing for assessment under its General Procedure. The application covers Eden Brew's recombinant beta-casein protein preparation (BCPP1), produced via microbial fermentation using engineered yeast, with a final decision expected by mid-November 2026. The company claims its animal-free casein generates 70% fewer emissions, uses only 5% of the land, and lowers water consumption by 99% compared to conventional dairy, targeting a $2.7 billion market for use in supplements, food fortification, sports nutrition, and the GLP-1 sector.Commonwealth Scientific and Industrial Research OrganisationReimagining food using fermentationCSIRO is advancing precision fermentation technology to produce animal-free proteins and ingredients, such as casein for dairy products, by engineering yeast strains to replicate the taste and nutrition of traditional animal sources. The organization highlights its partnership with startup Eden Brew to commercialize these sustainable alternatives, aiming to meet future global protein demands while reducing reliance on conventional agriculture.ABCEden Brew alternative milk startup attracts $25m in investments to bring synthetic dairy to marketEden Brew, an Australian startup, has raised $25 million to develop lab-cultured milk, aiming to bring animal-free dairy to supermarket shelves by 2025. The company, co-founded by Norco, uses precision fermentation to replicate dairy proteins, with investors including musicians and the Victorian government. It plans to lodge a food safety application early next year.InsidefmcgEden Brew raises $25m to propel animal-free dairy productionEden Brew raised $25 million to scale animal-free dairy protein production. Breakthrough Victoria contributed $6 million to relocate its headquarters from Sydney to Melbourne. The funding supports Australia's precision fermentation sector, which CSIRO projects to reach $1.5 billion by 2030.Startup DailyRock stars Bernard Fanning and Angus Stone, and Paralympian Dylan Alcott, back dairy replacement startup Eden Brew in $25 million Series ADairy alternative startup Eden Brew has raised $24.4 million in a Series A funding round to commercialize its animal-free milk and ice cream products. The venture, established as a joint-venture between dairy co-op Norco, CSIRO, and Main Sequence Ventures, utilizes fermentation technology to produce casein proteins without animals. The investment was led by Breakthrough Victoria with additional contributions from existing backers including Orkla and Digitalis Ventures.BreakthroughvictoriaEden Brew Media ReleaseBreakthrough Victoria is investing up to $6 million in Australian animal-free dairy company Eden Brew as part of its Series A funding round. This funding is aimed at enabling Eden Brew to begin commercial production of animal-free milk and ice cream, leveraging scientific advancements to address the growing demand for protein in a sustainable manner. The investment is significant as it aligns with the alt-proteins industry's expansion ahead of the AltProteins conference in Melbourne.HackadayThe Dawn Of Synthetic Milk: When Milk Becomes More Like BeerSynthetic milk is being produced via fermentation, with companies like Perfect Day using whey proteins and Eden Brew targeting caseins. Scaling remains a challenge, but bioreactor-based production could reduce land use and animal welfare concerns. Products may enter the regular milk market as supply chains expand.NatureAs the use of synthetic DNA expands, so does the potential to solve real-world problemsSynthetic biology's ability to read and write DNA is enabling real-world solutions, with mRNA vaccines and lab-grown milk as examples. Advances in gene synthesis have reduced costs and time, and companies like Eden Brew are developing dairy milk from microbes. The technology is expected to deliver impact at scale within a few years.The GuardianLeading the whey: the synthetic milk startups shaking up the dairy industrySynthetic milk startups like Eden Brew and All G Foods are developing lab-grown dairy products using precision fermentation. The technology aims to replicate cow's milk taste and mouthfeel, with Eden Brew targeting ice cream by December 2024 and milk by August 2024. Experts warn small-scale farmers may struggle as demand grows.